Inventiva (IVA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

IVA Inventiva

Watchlist

2.275
-0.005-0.22%

Close Dec 18 16:00 ET

2.250
-0.025-1.10%

Post 20:01 ET

198.10MMarket Cap-1.07P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Inventiva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswireDec 17 16:00 ET
Inventiva S.A. Boosts Capital With New Share and Warrant Issuance
TipRanksDec 16 16:27 ET
6-K: Report of foreign private issuer (related to financial reporting)
SECDec 16 16:18 ET · Announcements
Inventiva Splits CEO, Board Chairman Roles
MT NewswiresDec 16 10:00 ET
Inventiva Secures €21.4M, Successfully Completes First Tranche Of Multi-Tranche €348M Financing
BenzingaDec 16 02:50 ET
Inventiva Shareholders' Meeting Approves Key Resolutions
TipRanksDec 12 17:16 ET

Comments

Jaguar8

Dec 16 01:31

NEWS

$Inventiva (IVA.US)$
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million
Monday, 16th December at 2:30 am
◦ Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024.

◦ Proceeds from the completed first tranche to be primarily used to advance Inventiva's ...

Trytosaveabit

Oct 30 15:07

News

$Inventiva (IVA.US)$ Inventiva Announces The Recommendation Of The Fifth DMC Of The NATiV3 Phase 3 Clinical Trial With Lanifibranor In Patients With MASH
Benzinga· 3 mins ago
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.
The recommendation was based on the unblinded review by the DMC of safety data from more than 1000 patients randomized in the main and exploratory cohorts,...

$Inventiva (IVA.US)$https://www.moomoo.com/news/notice/301091081?ns_stock_id=79237851862280&client_hour_clock=24&main_broker=WwogIDEwMDgKXQ%3D%3D&sg_cid=103382313&skintype=1&jp_cid=103382313&futusource=news_stock_stockpagenews&level=0&global_content=%7B%22promote_content%22%3A%22mm%3Anotice%3A301091081%22%2C%22invite%22%3A103382313%7D&data_ticket=1725015159622121
Big buyout of the stocks?

Stock_Drift

Oct 14 10:35

Unusual Volume Ticks. 11:33am 10/14

$Semilux (SELX.US)$ $Bright Minds Biosciences (DRUG.US)$ $Gritstone Bio (GRTS.US)$ $B. Riley Financial (RILY.US)$ $Eco Wave Power (WAVE.US)$ $Rani Therapeutics (RANI.US)$ $Inventiva (IVA.US)$ $Expion360 (XPON.US)$ $Longboard Pharmaceuticals(Delisted) (LBPH.US)$ $Verb Technology (VERB.US)$ $Tevogen Bio Holdings (TVGN.US)$

Heat List

Overall

No Data